The Pyrophosphate Analogue Foscarnet Traps the Pre-translocational State of HIV-1 Reverse Transcriptase in a Brownian Ratchet Model of Polymerase Translocation

This publication has 45 references indexed in Scilit:

• Emerging anti-HIV drugs
  Emerging Drugs, 2005
• Antiviral drugs in current clinical use
  Published by Elsevier ,2004
• Foscarnet used in salvage therapy of HIV-1 patients harbouring multiple nucleotide excision mutations
  AIDS, 2004
• Relationship between 3′-Azido-3′-Deoxythymidine Resistance and Primer Unblocking Activity in Foscarnet-Resistant Mutants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase
  Journal of Virology, 2003
• Alkylglycerol Prodrugs of Phosphonoformate Are Potent In Vitro Inhibitors of Nucleoside-Resistant Human Immunodeficiency Virus Type 1 and Select for Resistance Mutations That Suppress Zidovudine Resistance
  Antimicrobial Agents and Chemotherapy, 2001
• HIV-1 Reverse Transcriptase Resistance to Nonnucleoside Inhibitors
  Biochemistry, 1996
• Characterisation of Foscarnet-Resistant Strains of Human Immunodeficiency Virus Type 1
  Virology, 1995
• Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by nonnucleoside inhibitors.
  Proceedings of the National Academy of Sciences, 1995
• Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates
  Antimicrobial Agents and Chemotherapy, 1995
• Antiviral effects of phosphonoformate (PFA, foscarnet sodium)
  Pharmacology & Therapeutics, 1982